• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Campbell Appoints Carrie Anderson Chief Financial Officer

    1/25/23 4:30:00 PM ET
    $CPB
    $EMBC
    $IART
    Packaged Foods
    Consumer Staples
    Medical/Dental Instruments
    Health Care
    Get the next $CPB alert in real time by email

    Campbell Soup Company (NYSE:CPB) today announced the appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer, effective Feb. 6.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230125005725/en/

    Carrie Anderson (Photo: Business Wire)

    Carrie Anderson (Photo: Business Wire)

    Anderson will lead Campbell's finance function, including controllership, corporate financial planning and analysis, corporate strategy and development, tax, treasury, internal audit, investor relations, transactional services and financial systems. She will report to Campbell's President and Chief Executive Officer Mark Clouse and become a member of the company's Operating Committee and a Corporate Officer. Anderson succeeds Mick Beekhuizen, who was appointed President of Campbell's Meals & Beverages division in November 2022.

    "I am delighted to welcome Carrie to our leadership team. She brings a wide range of diverse, strategic experience and financial discipline, and her expertise in capital management and deployment will help us continue to drive our growth plans and enhance our performance," said Clouse. "Her collaborative approach combined with a track record of driving transformation, delivering results and developing strong finance teams will be invaluable as we continue to build momentum in the business."

    Anderson brings a wealth of financial experience working in a variety of complex industries, as well as a background in manufacturing and engineering. She joins Campbell from Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, where she has served as Executive Vice President and Chief Financial Officer since 2019. Before Integra, Anderson spent seven years with Dover Corporation in several leadership roles, including Chief Accounting Officer/Corporate Controller, and Vice President and CFO for the company's engineered systems and printing and identification businesses. Previously, Anderson spent six years as Vice President and Chief Financial Officer of Delphi Product & Service Solutions, a division of Delphi Corporation. While at Delphi, she also held leadership positions in finance, treasury and investor relations. Anderson started her career with General Motors.

    Anderson earned her B.S. in chemical engineering from Purdue University and an MBA from Ball State University. She serves on the board of directors of Embecta Corp. (NASDAQ:EMBC) and is a member of its Audit and Nominating & Governance committees.

    About Campbell Soup Company

    For more than 150 years, Campbell (NYSE:CPB) has been connecting people through food they love. Generations of consumers have trusted Campbell to provide delicious and affordable food and beverages. Headquartered in Camden, N.J. since 1869, Campbell generated fiscal 2022 net sales of nearly $8.6 billion. Our portfolio includes iconic brands such as Campbell's, Cape Cod, Goldfish, Kettle Brand, Lance, Late July, Milano, Pace, Pacific Foods, Pepperidge Farm, Prego, Snyder's of Hanover, Swanson and V8. Campbell has a heritage of giving back and acting as a good steward of the environment. The company is a member of the Standard & Poor's 500 as well as the FTSE4Good and Bloomberg Gender-Equality Indices. For more information, visit www.campbellsoupcompany.com or follow company news on Twitter via @CampbellSoupCo.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005725/en/

    Get the next $CPB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CPB
    $EMBC
    $IART

    CompanyDatePrice TargetRatingAnalyst
    The Campbell's Company
    $CPB
    3/12/2026$20.00Equal Weight → Underweight
    Wells Fargo
    The Campbell's Company
    $CPB
    8/20/2025$33.00Neutral
    Analyst
    The Campbell's Company
    $CPB
    8/7/2025$34.00Overweight → Neutral
    Piper Sandler
    The Campbell's Company
    $CPB
    6/20/2025Buy → Hold
    Argus
    The Campbell's Company
    $CPB
    4/23/2025$36.00Sell
    UBS
    Embecta Corp.
    $EMBC
    4/10/2025$15.00Neutral
    Mizuho
    Integra LifeSciences Holdings Corporation
    $IART
    3/31/2025Hold → Buy
    Argus
    The Campbell's Company
    $CPB
    3/17/2025Overweight → Equal Weight
    Consumer Edge Research
    More analyst ratings

    $CPB
    $EMBC
    $IART
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Campbell's Company downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded The Campbell's Company from Equal Weight to Underweight and set a new price target of $20.00

    3/12/26 8:42:44 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Analyst resumed coverage on Campbell Soup with a new price target

    Analyst resumed coverage of Campbell Soup with a rating of Neutral and set a new price target of $33.00

    8/20/25 8:33:18 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Campbell Soup downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Campbell Soup from Overweight to Neutral and set a new price target of $34.00

    8/7/25 7:33:36 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & PRESIDENT, INTERNATIONAL Singh Harvinder converted options into 20,138 shares and covered exercise/tax liability with 6,652 shares, increasing direct ownership by 61% to 35,422 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    3/12/26 6:10:55 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    EVP & President, CSS Mcbreen Michael J. covered exercise/tax liability with 9,601 shares, decreasing direct ownership by 14% to 60,743 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    3/12/26 5:18:04 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    EVP & President, TT Davis Robert T. Jr. covered exercise/tax liability with 9,174 shares, decreasing direct ownership by 12% to 66,387 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    3/12/26 5:17:35 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    SEC Filings

    View All

    Embecta Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Embecta Corp. (0001872789) (Filer)

    3/19/26 8:00:50 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by The Campbell's Company

    10-Q - CAMPBELL'S Co (0000016732) (Filer)

    3/11/26 7:23:18 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    The Campbell's Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CAMPBELL'S Co (0000016732) (Filer)

    3/11/26 7:17:14 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

    PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("Embecta") (NASDAQ:EMBC), a global leader in diabetes care technology, today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited ("Owen Mumford"), a privately held, UK‑based innovator and manufacturer of medical devices and drug‑delivery technologies, in a transaction valued at up to £150 million. Under the terms of the agreement, embecta will acquire Owen Mumford for an upfront cash payment of £100 million at closing (subject to customary adjustments, including for closing net cash), and up to an additional £50 million in performance-based payments based on net sales of the A

    3/19/26 6:30:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

    MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin

    3/17/26 7:45:00 AM ET
    $IART
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    Campbell's Appoints Joshua Levine Chief Investor Relations Officer

    Rebecca Gardy Announces Retirement The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Joshua Levine as Chief Investor Relations Officer, effective March 18, 2026. Levine will report to Chief Financial Officer Todd Cunfer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260313648265/en/Joshua Levine Levine will lead the company's Investor Relations function, overseeing engagement with the investment community and supporting transparent, consistent communication with shareholders. He succeeds Rebecca Gardy, who announced her retirement from the company after six years of leadership in investor rel

    3/13/26 12:25:00 PM ET
    $CPB
    $SMPL
    $SOVO
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Graves Jeffrey A bought $102,150 worth of shares (9,000 units at $11.35), increasing direct ownership by 28% to 41,086 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    11/6/25 4:05:46 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    5/23/25 4:35:56 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    2/25/25 4:26:16 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Leadership Updates

    Live Leadership Updates

    View All

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

    MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin

    3/17/26 7:45:00 AM ET
    $IART
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    Campbell's Appoints Joshua Levine Chief Investor Relations Officer

    Rebecca Gardy Announces Retirement The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Joshua Levine as Chief Investor Relations Officer, effective March 18, 2026. Levine will report to Chief Financial Officer Todd Cunfer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260313648265/en/Joshua Levine Levine will lead the company's Investor Relations function, overseeing engagement with the investment community and supporting transparent, consistent communication with shareholders. He succeeds Rebecca Gardy, who announced her retirement from the company after six years of leadership in investor rel

    3/13/26 12:25:00 PM ET
    $CPB
    $SMPL
    $SOVO
    Packaged Foods
    Consumer Staples

    Campbell's Appoints Cassandra Green Chief Supply Chain Officer

    The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Cassandra Green as Chief Supply Chain Officer, effective immediately. Green will report to President and Chief Executive Officer Mick Beekhuizen and will join the company's Operating Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303153016/en/Cassandra Green In this elevated role, Green will continue to lead Campbell's end-to-end supply chain, including customer logistics and planning, procurement, operational excellence, manufacturing and supply chain category leadership. She will also assume responsibility for food safety and qual

    3/3/26 4:30:00 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Financials

    Live finance-specific insights

    View All

    embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

    PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("Embecta") (NASDAQ:EMBC), a global leader in diabetes care technology, today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited ("Owen Mumford"), a privately held, UK‑based innovator and manufacturer of medical devices and drug‑delivery technologies, in a transaction valued at up to £150 million. Under the terms of the agreement, embecta will acquire Owen Mumford for an upfront cash payment of £100 million at closing (subject to customary adjustments, including for closing net cash), and up to an additional £50 million in performance-based payments based on net sales of the A

    3/19/26 6:30:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Campbell's Reports Second Quarter Fiscal 2026 Results

    Net Sales decreased 5% to $2.6 billion and decreased 3% on an organic basis. Earnings Before Interest and Taxes (EBIT) decreased to $273 million. Adjusted EBIT decreased 24% to $282 million. Earnings Per Share (EPS) decreased to $0.48. Adjusted EPS decreased 31% to $0.51. Fiscal year-to-date cash flow from operations was $740 million; returned $263 million to shareholders including $237 million in dividends. January storm-related shipment delays and associated supply chain costs impacted net sales by approximately 1%, adjusted EBIT by approximately $14 million and adjusted EPS by approximately $0.04 per share in the quarter. Updates full-year fiscal 2026 guidance. The Cam

    3/11/26 7:15:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

    PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) --  Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Reported revenues were $434.9 million, representing a decrease of 1.7% on a reported basis and 2.5% on an organic basis compared to the fourth quarter of 2024. GAAP earnings per diluted share were $(0.02), compared to $0.25 in the fourth quarter of 2024.Adjusted earnings per diluted share were $0.83, compared to $0.97 in the fourth quarter of 2024. Full-Year 2025 Reported revenues were $1,635.2 million, representing an increase of 1.5% on a reported basis and

    2/26/26 6:00:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Integra LifeSciences Holdings Corporation

    SC 13G - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 5:20:30 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Integra LifeSciences Holdings Corporation

    SC 13G/A - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 12:54:20 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Embecta Corp.

    SC 13G/A - Embecta Corp. (0001872789) (Subject)

    11/8/24 10:57:43 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care